Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of circadian rhythm diseases and disorders; Pharmaceutical preparations for the treatment of Non-24-Hour Sleep-Wake Disorder; Pharmaceutical preparations for the treatment of jet lag disorder; Pharmaceutical preparations for the treatment of Smith-Magenis Syndrome; Pharmaceutical preparations for the treatment of Dela...

Pharmaceutical preparations for use in the treatment of diseases and disorders of the central nervous system, namely, diseases and disorders related to circadian rhythm; Pharmaceutical preparations for use in the treatment of diseases and disorders having an impact on the central nervous system, namely, diseases and disorders having an impact on circadian rhythm; and Pharmaceutical preparations for use in the treatment of diseases and disorders having a central nervous system manifestation, n...

Pharmaceutical preparations for use in the treatment of diseases and disorders of the central nervous system, namely, diseases and disorders related to circadian rhythm; diseases and disorders having an impact on the central nervous system,, namely, diseases and disorders having an impact on circadian rhythm; and diseases and disorders having a central nervous system manifestation,, namely, diseases and disorders manifesting in symptoms related to circadian rhythm